The vaping cessation pill, varenicline, is garnering attention as a potent tool in the fight against nicotine addiction among teens and young adults.Recent findings from a study conducted by Harvard-affiliated Mass General Brigham indicate that those who use this FDA-approved smoking cessation medication have more than triple the success rate in quitting vaping compared to their peers receiving only behavioral counseling.